The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 74 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Liver Cirrhosis  [Clear All Filters]
2010
Cholongitas, E., Calvaruso V., Betrosian A., Senzolo M., Shaw S., O'Beirne J., et al. (2010).  Critically ill patients with cirrhosis and low serum sodium.. J Clin Gastroenterol. 44(7), 523-4; author reply 524-5.
Cholongitas, E., Xirouchakis E., Garcovich M., & Burroughs A. K. (2010).  Evaluation of renal function in patients with cirrhosis.. J Hepatol. 53(3), 589.
Sinakos, E., Perifanis V., Vlachaki E., Tsatra I., & Raptopoulou-Gigi M. (2010).  Is liver stiffness really unrelated to liver iron concentration?. Br J Haematol. 150(2), 247-8.
Cholongitas, E., Tsochatzis E., Goulis J., & Burroughs A. K. (2010).  Noninvasive tests for evaluation of fibrosis in HCV recurrence after liver transplantation: a systematic review.. Transpl Int. 23(9), 861-70.
Polyzos, S. Alexandros, Kountouras J., & Zavos C. (2010).  Nonlinear distribution of adiponectin in patients with nonalcoholic fatty liver disease limits its use in linear regression analysis.. J Clin Gastroenterol. 44(3), 229-30; author reply 230-1.
Chang, C. Y., Martin P., Fotiadu A., & Hytiroglou P. (2010).  A patient with chronic hepatitis B and regression of fibrosis during treatment.. Semin Liver Dis. 30(3), 296-301.
Thielmann, M., Mechmet A., Neuhäuser M., Wendt D., Tossios P., Canbay A., et al. (2010).  Risk prediction and outcomes in patients with liver cirrhosis undergoing open-heart surgery.. Eur J Cardiothorac Surg. 38(5), 592-9.
Triantos, C. K., Samonakis D., Thalheimer U., Cholongitas E., Senzolo M., Marelli L., et al. (2010).  Terlipressin therapy for renal failure in cirrhosis.. Eur J Gastroenterol Hepatol. 22(4), 481-6.
2009
Senzolo, M., Cholongitas E., Burra P., Leandro G., Thalheimer U., Patch D., et al. (2009).  beta-Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis.. Liver Int. 29(8), 1189-93.
Cholongitas, E., Senzolo M., Patch D., Shaw S., O'Beirne J., & Burroughs A. K. (2009).  Cirrhotics admitted to intensive care unit: the impact of acute renal failure on mortality.. Eur J Gastroenterol Hepatol. 21(7), 744-50.
Papatheodoridis, G. V., Cholongitas E., Archimandritis A. J., & Burroughs A. K. (2009).  Current management of hepatitis B virus infection before and after liver transplantation.. Liver Int. 29(9), 1294-305.
Senzolo, M., Cholongitas E., Thalheimer U., Riddell A., Agarwal S., Mallett S., et al. (2009).  Heparin-like effect in liver disease and liver transplantation.. Clin Liver Dis. 13(1), 43-53.
Pavlidis, T. E., Symeonidis N. G., Psarras K., Skouras C., Kontoulis T. M., Ballas K., et al. (2009).  Laparoscopic cholecystectomy in patients with cirrhosis of the liver and symptomatic cholelithiasis.. JSLS. 13(3), 342-5.
Savvidou, S., Hytiroglou P., Orfanou-Koumerkeridou H., Panderis A., Frantzoulis P., & Goulis J. (2009).  Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD.. J Clin Gastroenterol. 43(8), 765-72.
Manousou, P., Samonakis D., Cholongitas E., Patch D., O'Beirne J., Dhillon A. P., et al. (2009).  Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy.. Liver Transpl. 15(12), 1783-91.
Cholongitas, E., Calvaruso V., Senzolo M., Patch D., Shaw S., O'Beirne J., et al. (2009).  RIFLE classification as predictive factor of mortality in patients with cirrhosis admitted to intensive care unit.. J Gastroenterol Hepatol. 24(10), 1639-47.
Tsochatzis, E., Manolakopoulos S., Papatheodoridis G. V., Hadziyannis E., Triantos C., Zisimopoulos K., et al. (2009).  Serum HCV RNA levels and HCV genotype do not affect insulin resistance in nondiabetic patients with chronic hepatitis C: a multicentre study.. Aliment Pharmacol Ther. 30(9), 947-54.
Kim, S., Kotoula V., Hytiroglou P., Zardavas D., & Zhang L. (2009).  Significance of increased expression of decoy receptor 3 in chronic liver disease.. Dig Liver Dis. 41(8), 591-8.
Papatheodoridis, G. V., Chrysanthos N., Cholongitas E., Pavlou E., Apergis G., Tiniakos D. G., et al. (2009).  Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease.. J Hepatol. 51(5), 931-8.
2005
Schiano, T. D., Azeem S., Bodian C. A., Bodenheimer H. C., Merati S., Thung S. N., et al. (2005).  Importance of specimen size in accurate needle liver biopsy evaluation of patients with chronic hepatitis C.. Clin Gastroenterol Hepatol. 3(9), 930-5.
2003
Kotzampassi, K., Metaxas G., Paramythiotis D., Pidonia I., Rekka H., Karamouzis M., et al. (2003).  The influence of continuous seven-day elevated intra-abdominal pressure in the renal perfusion in cirrhotic rats.. J Surg Res. 115(1), 133-8.
2002
Kotoula, V., Hytiroglou P., Pyrpasopoulou A., Saxena R., Thung S. N., & Papadimitriou C. S. (2002).  Expression of human telomerase reverse transcriptase in regenerative and precancerous lesions of cirrhotic livers.. Liver. 22(1), 57-69.
Efremidis, S. C., & Hytiroglou P. (2002).  The multistep process of hepatocarcinogenesis in cirrhosis with imaging correlation.. Eur Radiol. 12(4), 753-64.
1998
Hytiroglou, P., Kotoula V., Thung S. N., Tsokos M., Fiel M. I., & Papadimitriou C. S. (1998).  Telomerase activity in precancerous hepatic nodules.. Cancer. 82(10), 1831-8.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.